3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Glioblastoma
4
Astrocytoma
3
Oligodendroglioma
2
Glioma
2
Esophageal Neoplasms
2
Brain Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Prostatic Neoplasms
1
Proliferative Breast Disease
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Optic Nerve Glioma
1
Neoplasm Metastasis
1
Head and Neck Neoplasms
1
Gliosarcoma
1
Esophageal Squamous Cell Carcinoma
1
Ependymoma
1
Childhood Brain Neoplasm
1
Carcinoma, Squamous Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Breast Neoplasms, Male
1
Breast Neoplasms
1
Adenocarcinoma Of Esophagus
1
Interventions
Carboplatin
5
pembrolizumab
4
Trastuzumab
4
Oxaliplatin
4
Fluorouracil
4
Cyclophosphamide
4
Radiotherapy
3
Paclitaxel
3
Endoscopy
3
Docetaxel
3
Cytarabine
3
Chemoradiotherapy
3
Capecitabine
3
toripalimab
2
Tretinoin
2
Surgical Procedures, Operative
2
Standard of Care
2
Observation
2
Neoadjuvant Therapy
2
Metformin
2
Magnetic Resonance Imaging
2
Leucovorin
2
Irinotecan
2
Immunotherapy
2
Immune Checkpoint Inhibitors
2
Epirubicin
2
Drug Therapy
2
Doxorubicin
2
Cisplatin
2
Blood Specimen Collection
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Pathologic Complete Response
×
Dynamic Contrast Enhanced Magnetic Resonance Imaging
×
Clear all
NCT03474341
2020-11-16
PRIDE
UMC Utrecht
Unknown
200 enrolled